Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Dec;94(6):2377–2384. doi: 10.1172/JCI117603

Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

J C Cohen 1, Z Wang 1, S M Grundy 1, M R Stoesz 1, R Guerra 1
PMCID: PMC330067  PMID: 7989594

Abstract

Genetic factors have been shown to play an important role in determining interindividual variation in plasma HDL-C levels, but the specific genetic determinants of HDL cholesterol (HDL-C) levels have not been elucidated. In this study, the effects of variation in the genomic regions encoding hepatic lipase, apolipoprotein AI/CIII/AIV, and the cholesteryl ester transfer protein on plasma HDL-C levels were examined in 73 normotriglyceridemic, Caucasian nuclear families. Genetic factors accounted for 56.5 +/- 13% of the interindividual variation in plasma HDL-C levels. For each candidate gene, adjusted plasma HDL-C levels of sibling pairs who shared zero, one, or two parental alleles identical-by-descent were compared using sibling-pair linkage analysis. Allelic variation in the genes encoding hepatic lipase and apolipoprotein AI/CIII/AIV accounted for 25 and 22%, respectively, of the total interindividual variation in plasma HDL-C levels. In contrast, none of the variation in plasma HDL-C levels could be accounted for by allelic variation in the cholesteryl ester transfer protein. These findings indicate that a major fraction of the genetically determined variation in plasma HDL-C levels is conferred by allelic variation at the hepatic lipase and the apolipoprotein AI/CIII/AIV gene loci.

Full text

PDF
2377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos C. I., Elston R. C., Srinivasan S. R., Wilson A. F., Cresanta J. L., Ward L. J., Berenson G. S. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study. Genet Epidemiol. 1987;4(2):115–128. doi: 10.1002/gepi.1370040206. [DOI] [PubMed] [Google Scholar]
  2. Applebaum-Bowden D., Haffner S. M., Wahl P. W., Hoover J. J., Warnick G. R., Albers J. J., Hazzard W. R. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis. 1985 May-Jun;5(3):273–282. doi: 10.1161/01.atv.5.3.273. [DOI] [PubMed] [Google Scholar]
  3. Auwerx J. H., Babirak S. P., Hokanson J. E., Stahnke G., Will H., Deeb S. S., Brunzell J. D. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet. 1990 Mar;46(3):470–477. [PMC free article] [PubMed] [Google Scholar]
  4. Beckmann J. S., Tomfohrde J., Barnes R. I., Williams M., Broux O., Richard I., Weissenbach J., Bowcock A. M. A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 55 polymorphic microsatellites. Hum Mol Genet. 1993 Dec;2(12):2019–2030. doi: 10.1093/hmg/2.12.2019. [DOI] [PubMed] [Google Scholar]
  5. Berchtold P., Berger M., Jörgens V., Daweke C., Chantelau E., Gries F. A., Zimmermann H. Cardiovascular risk factors and HDL-cholesterol levels in obesity. Int J Obes. 1981;5(1):1–10. [PubMed] [Google Scholar]
  6. Bhattacharya S., Ameis D., Cullen P., Narcisi T. M., Bayliss J., Greten H., Schotz M. C., Scott J. VNTR polymorphism in the hepatic lipase gene (LIPC). Nucleic Acids Res. 1991 Sep 25;19(18):5088–5088. doi: 10.1093/nar/19.18.5088-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blades B., Vega G. L., Grundy S. M. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb. 1993 Aug;13(8):1227–1235. doi: 10.1161/01.atv.13.8.1227. [DOI] [PubMed] [Google Scholar]
  8. Boerwinkle E., Leffert C. C., Lin J., Lackner C., Chiesa G., Hobbs H. H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992 Jul;90(1):52–60. doi: 10.1172/JCI115855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohen J. C., Chiesa G., Hobbs H. H. Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest. 1993 Apr;91(4):1630–1636. doi: 10.1172/JCI116370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Connelly P. W., Maguire G. F., Lee M., Little J. A. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 1990 Jan-Feb;10(1):40–48. doi: 10.1161/01.atv.10.1.40. [DOI] [PubMed] [Google Scholar]
  11. Craig W. Y., Palomaki G. E., Haddow J. E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989 Mar 25;298(6676):784–788. doi: 10.1136/bmj.298.6676.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dammerman M., Sandkuijl L. A., Halaas J. L., Chung W., Breslow J. L. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4562–4566. doi: 10.1073/pnas.90.10.4562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Deeb S. S., Cheung M. C., Peng R. L., Wolf A. C., Stern R., Albers J. J., Knopp R. H. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins. J Biol Chem. 1991 Jul 25;266(21):13654–13660. [PubMed] [Google Scholar]
  14. Freeman D. J., Griffin B. A., Murray E., Lindsay G. M., Gaffney D., Packard C. J., Shepherd J. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest. 1993 Oct;23(10):630–640. doi: 10.1111/j.1365-2362.1993.tb00724.x. [DOI] [PubMed] [Google Scholar]
  15. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  16. Friedlander Y., Kark J. D., Stein Y. Complex segregation analysis of low levels of plasma high-density lipoprotein cholesterol in a sample of nuclear families in Jerusalem. Genet Epidemiol. 1986;3(5):285–297. doi: 10.1002/gepi.1370030502. [DOI] [PubMed] [Google Scholar]
  17. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R., Jr, Bangdiwala S., Tyroler H. A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989 Jan;79(1):8–15. doi: 10.1161/01.cir.79.1.8. [DOI] [PubMed] [Google Scholar]
  18. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  19. Grosser J., Schrecker O., Greten H. Function of hepatic triglyceride lipase in lipoprotein metabolism. J Lipid Res. 1981 Mar;22(3):437–442. [PubMed] [Google Scholar]
  20. Gylling H., Vega G. L., Grundy S. M. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res. 1992 Oct;33(10):1527–1539. [PubMed] [Google Scholar]
  21. Haseman J. K., Elston R. C. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972 Mar;2(1):3–19. doi: 10.1007/BF01066731. [DOI] [PubMed] [Google Scholar]
  22. Hegele R. A., Little J. A., Vezina C., Maguire G. F., Tu L., Wolever T. S., Jenkins D. J., Connelly P. W. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993 May;13(5):720–728. doi: 10.1161/01.atv.13.5.720. [DOI] [PubMed] [Google Scholar]
  23. Heller D. A., de Faire U., Pedersen N. L., Dahlén G., McClearn G. E. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993 Apr 22;328(16):1150–1156. doi: 10.1056/NEJM199304223281603. [DOI] [PubMed] [Google Scholar]
  24. Hudson T. J., Engelstein M., Lee M. K., Ho E. C., Rubenfield M. J., Adams C. P., Housman D. E., Dracopoli N. C. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics. 1992 Jul;13(3):622–629. doi: 10.1016/0888-7543(92)90133-d. [DOI] [PubMed] [Google Scholar]
  25. Humphries S. E. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis. 1988 Aug;72(2-3):89–108. doi: 10.1016/0021-9150(88)90069-x. [DOI] [PubMed] [Google Scholar]
  26. Inazu A., Brown M. L., Hesler C. B., Agellon L. B., Koizumi J., Takata K., Maruhama Y., Mabuchi H., Tall A. R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990 Nov 1;323(18):1234–1238. doi: 10.1056/NEJM199011013231803. [DOI] [PubMed] [Google Scholar]
  27. Jackson R. L., Yates M. T., McNerney C. A., Kashyap M. L. Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm Metab Res. 1990 May;22(5):289–294. doi: 10.1055/s-2007-1004904. [DOI] [PubMed] [Google Scholar]
  28. Karathanasis S. K. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6374–6378. doi: 10.1073/pnas.82.19.6374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kuusi T., Kesäniemi Y. A., Vuoristo M., Miettinen T. A., Koskenvuo M. Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis. 1987 Jul-Aug;7(4):421–425. doi: 10.1161/01.atv.7.4.421. [DOI] [PubMed] [Google Scholar]
  30. Kuusi T., Saarinen P., Nikkilä E. A. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980 Aug;36(4):589–593. doi: 10.1016/0021-9150(80)90251-8. [DOI] [PubMed] [Google Scholar]
  31. Lackner C., Cohen J. C., Hobbs H. H. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993 Jul;2(7):933–940. doi: 10.1093/hmg/2.7.933. [DOI] [PubMed] [Google Scholar]
  32. Luo X. Y., Evans G. A., Litt M. Dinucleotide repeat polymorphism at the D11S490 locus. Nucleic Acids Res. 1990 Dec 25;18(24):7470–7470. doi: 10.1093/nar/18.24.7470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lusis A. J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res. 1988 Apr;29(4):397–429. [PubMed] [Google Scholar]
  34. Marcel Y. L., McPherson R., Hogue M., Czarnecka H., Zawadzki Z., Weech P. K., Whitlock M. E., Tall A. R., Milne R. W. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest. 1990 Jan;85(1):10–17. doi: 10.1172/JCI114397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McGowan M. W., Artiss J. D., Strandbergh D. R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983 Mar;29(3):538–542. [PubMed] [Google Scholar]
  36. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  37. Mitchell-Olds T., Bergelson J. Statistical genetics of an annual plant, Impatiens capensis. I. Genetic basis of quantitative variation. Genetics. 1990 Feb;124(2):407–415. doi: 10.1093/genetics/124.2.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Moll P. P., Sing C. F., Williams R. R., Mao S. J., Kottke B. A. The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees. Am J Hum Genet. 1986 Mar;38(3):361–372. [PMC free article] [PubMed] [Google Scholar]
  39. Ng D. S., Leiter L. A., Vezina C., Connelly P. W., Hegele R. A. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J Clin Invest. 1994 Jan;93(1):223–229. doi: 10.1172/JCI116949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ordovas J. M., Civeira F., Genest J., Jr, Craig S., Robbins A. H., Meade T., Pocovi M., Frossard P. M., Masharani U., Wilson P. W. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 1991 Mar;87(1):75–86. doi: 10.1016/0021-9150(91)90234-t. [DOI] [PubMed] [Google Scholar]
  41. Reina M., Deeb S. SSCP polymorphism in the human hepatic triglyceride lipase (LIPC) gene. Hum Mol Genet. 1992 Sep;1(6):453–453. doi: 10.1093/hmg/1.6.453-a. [DOI] [PubMed] [Google Scholar]
  42. Schieken R. M. Effect of exercise on lipids. Ann N Y Acad Sci. 1991;623:269–274. doi: 10.1111/j.1749-6632.1991.tb43736.x. [DOI] [PubMed] [Google Scholar]
  43. Shen Y., Thompson A. T., Holman K., Callen D. F., Sutherland G. R., Richards R. I. Four dinucleotide repeat polymorphisms on human chromosome 16 at D16S289, D16S318, D16S319 and D16S320. Hum Mol Genet. 1992 Dec;1(9):773–773. doi: 10.1093/hmg/1.9.773. [DOI] [PubMed] [Google Scholar]
  44. Steinmetz J., Boerwinkle E., Gueguen R., Visvikis S., Henny J., Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 1992 Feb;92(2-3):219–227. doi: 10.1016/0021-9150(92)90281-k. [DOI] [PubMed] [Google Scholar]
  45. Sutherland W. H., Temple W. A., Nye E. R., Herbison G. P. Adiposity, lipids, alcohol consumption, smoking, and gender. Am J Clin Nutr. 1980 Dec;33(12):2581–2587. doi: 10.1093/ajcn/33.12.2581. [DOI] [PubMed] [Google Scholar]
  46. Tall A. R. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993 Aug;34(8):1255–1274. [PubMed] [Google Scholar]
  47. Wannamethee G., Shaper A. G. Blood lipids: the relationship with alcohol intake, smoking, and body weight. J Epidemiol Community Health. 1992 Jun;46(3):197–202. doi: 10.1136/jech.46.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Weber J. L., Kwitek A. E., May P. E. Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci. Nucleic Acids Res. 1990 Jul 11;18(13):4036–4036. doi: 10.1093/nar/18.13.4036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weissenbach J., Gyapay G., Dib C., Vignal A., Morissette J., Millasseau P., Vaysseix G., Lathrop M. A second-generation linkage map of the human genome. Nature. 1992 Oct 29;359(6398):794–801. doi: 10.1038/359794a0. [DOI] [PubMed] [Google Scholar]
  50. Wiklund O., Wilhelmsen L., Elmfeldt D., Wedel H., Valek J., Gustafson A. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis. 1980 Sep;37(1):47–53. doi: 10.1016/0021-9150(80)90092-1. [DOI] [PubMed] [Google Scholar]
  51. Xu C. F., Angelico F., Del Ben M., Humphries S. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol. 1993;10(2):113–122. doi: 10.1002/gepi.1370100204. [DOI] [PubMed] [Google Scholar]
  52. Zuliani G., Hobbs H. H. Tetranucleotide repeat polymorphism in the apolipoprotein C-III gene. Nucleic Acids Res. 1990 Jul 25;18(14):4299–4299. [PMC free article] [PubMed] [Google Scholar]
  53. von Eckardstein A., Holz H., Sandkamp M., Weng W., Funke H., Assmann G. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J Clin Invest. 1991 May;87(5):1724–1731. doi: 10.1172/JCI115190. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES